drugset / Trial / NCT02278276
Assessing the Safety and Bioactivity of SG1002 in Heart Failure Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and benefits of SG1002, including overcoming deficits in circulating hydrogen sulfide and nitrite found in heart failure patients, with secondary endpoints focused on improving clinical endpoints.
Timeline
- Start
- 2016-04
- Primary completion
- 2018-04
- Completion
- 2018-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | sodium polysulthionate | Unknown | 800 mg | — |